Q-Pharm have an extensive range of capabilities
Early Phase Clinical Trial Specialists
Q-Pharm provides comprehensive trial services to its clients
Q-Pharm has conducted studies with vaccines, biological and pharmaceutical agents, using a broad range of traditional and modern delivery techniques.
Q-Pharm’s experience with comparative pharmacokinetic studies is unrivalled in the region. Our experience base includes:
- complex designs (steady-state, 3-way and 4-way crossover studies)
- early stage vaccine trials (including GMOs)
- large early phase studies (up to 120 volunteers)
- unconventional study designs
- extensive experience with food effect studies
Sharon Rankine is our Clinical Operations Manager and is a highly experienced coronary and critical care nurse with extensive experience in healthy volunteer and patient based clinical trials.
First in Human Studies
With over 40 first-in-human studies under our belt you can be sure your trial is in good hands
Q-Pharm is well experienced with conducting pivotal ‘first time in human’ clinical studies. Our company conducts approximately 30 clinical studies per year, many of which are complex early-phase or first-in-human investigations. Q-Pharm staff, particularly our medical officers are highly experienced with a wide variety of investigational product types using various routes of administration.
Dr Paul Griffin leads our skilled team of clinical trial doctors. Dr Griffin is an infectious diseases physician and microbiologist. Dr Griffin is the Principal Investigator for the majority of Q-Pharm clinical trials and oversees all medical aspects of our clinical trials program.
Healthy and patient based studies
Connections with local hospitals and specialists gives us access to patients all around Queensland with specific health conditions
- First in human
- BA/BE/PK studies
- Proof of Concept studies
- SAD/MAD/Food effect studies
- Long term confinements (28 days+)
- Infectious agent – vaccines and therapeutics
- Anaesthetic agents
- Malaria challenge models
- Glucose clamp
- Cytotoxic agents and immuno-oncology
- Medical devices
- Inhaled deliveries/devices
- Novel vaccine delivery
- Ethnobridging & other ethnopharmacology studies
Q-Pharm is at the forefront of innovation within the pharmaceutical and biotech industry.
Together with our clients we have completed many complex trials including ones solving contemporary diseases and viruses such as Ebola and Hendra as well as using innovative technology such as Needle-free Nanopatch technology.
Proven quality system
At Q-Pharm, quality is and always has been at the heart of everything we do
Many of the clinical studies conducted at Q-Pharm have been accepted internationally for submissions to regulators in Australia, Europe and North America. Q-Pharm also has a history of successful regulatory inspections and client audits. Q-Pharm has had inspections by agencies from North America (FDA), Europe (ANSM, AEMPS) and South America (ANVISA).
Our QA team is led by Andrew King, responsible for the company's Quality System as well as the role of document manager and archivist.
Q-Pharm has specialised expertise in a great number of therapeutic areas
We have run a large number of trials in a wide range of therapeutic areas including:
- Malaria challenge studies
- Vaccine studies
- Infectious Diseases
- Medical Imaging
Streamlined recruitment process, 10,000+ active participants in database
Q-Pharm prides itself on timely recruitment of volunteers to ensure your clinical trial proceeds without delay.
With a recruitment team boasting over 20 years of clinical trial recruitment experience and state of the art marketing and software systems, we can recruit even the most difficult studies.